Krystof S. Bankiewicz

Founder at Voyager Therapeutics, Inc.

Krystof S. Bankiewicz

Krystof S. Bankiewicz

Founder at Voyager Therapeutics, Inc.

Overview
Career Highlights

Columbus Children's Foundation
Voyager Therapeutics, Inc.

RelSci Relationships

2806

Number of Boards

1

Relationships
RelSci Relationships are individuals Krystof S. Bankiewicz likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Venture Partner at Third Rock Ventures LLC

Relationship likelihood: Strong

Co-Founder at Third Rock Ventures LLC

Relationship likelihood: Strong

President & Chief Executive Officer at Voyager Therapeutics, Inc.

Relationship likelihood: Strong

Former President of Genzyme Europe & General Manager of Cardiovascular Business at Genzyme Corp.

Relationship likelihood: Strong

President, Chief Executive Officer & Representative Director at SanBio Co., Ltd.

Relationship likelihood: Strong

Former Chief Scientific Officer at Voyager Therapeutics, Inc.

Relationship likelihood: Strong

Member, Scientific Advisory Board at SanBio, Inc.

Relationship likelihood: Strong

Member, Scientific Advisory Board at SanBio, Inc.

Relationship likelihood: Strong

Member, Scientific Advisory Board at SanBio, Inc.

Relationship likelihood: Strong

Member, Scientific Advisory Board at SanBio, Inc.

Relationship likelihood: Strong

Paths to Krystof S. Bankiewicz
Potential Connections via
Relationship Science
You
Krystof S. Bankiewicz
Founder at Voyager Therapeutics, Inc.
Education
MD Unknown

The Jagiellonian University is the oldest higher education institution in Poland and one of the oldest in Europe. It was founded on 12 May 1364 by the Polish king Casimir the Great. The Jubilee year 2014 marked the 650th anniversary of this remarkable event. Since its very beginning, the Jagiellonian University has been an international institution. Poles, Ruthenians, Lithuanians, Hungarians, Germans, Czechs, the Swiss, the English, the Dutch, the French the Spanish, Italians, and even Tatars studied here in the old days. Further development of the University has been inextricably bound with the turbulent and often tragic history of Poland. The institution managed to survive both the partitions of Poland by Russia, Prussia and Austria, and the two world wars, serving as a guardian of Polish culture and identity and educating successive generations of Poles, as well as members of other nations, significantly contributing to the intellectual heritage of Europe. Some of the Jagiellonian University students and academics have been major historical figures, including world famous scholars, such as Nicolaus Copernicus or Karol Olszewski, as well as Karol Wojtyla, the future Pope John Paul II. Today, the Jagiellonian University comprises 16 Faculties, where nearly 4 thousand academic staff conduct research and provide education to over 40 thousand students, within the framework of more than 80 different fields of study. The eminent researchers and state-of-the-art infrastructure make the JU one of the leading Polish scientific institutions, collaborating with major academic centres from all over the world. The Jagiellonian University is also home to about 150 student societies, where young researchers pursue their academic interests and develop friendships with people who share their passion. The university's prestige in both Poland and abroad is illustrated by its widely recognised research achievements. The scientists and physicians from the JU Medical College carry out pioneer studies, e.g. in cardiac surgery, urology and neurology, often leading to the development of novel treatment methods. Their findings have been published in some of the most prestigious international journals, for instance European Journal of Cardio-Thoracic Medicine, New England Journal of Medicine, and Lancet. JU archaeologists explore the secrets of ancient sites in various parts of the world, including Egypt, Cyprus, Central America, South Asia and Altay. The astronomers take part in the most important international projects in their field, including H.E.S.S. and VIPERS, whereas the results of research by JU biotechnologists have been published in such reputable specialist journals as Bioorganic and Medicinal Chemistry, Molecular Ecology Resources or European Journal of Human Genetics. These are only some examples of remarkable successes for which the Jagiellonian University has been famous in recent years. The current position of the JU is also reflected in the growing number of patent applications and patents – in the year 2017 alone, there were as many as 55 patents granted to its academic staff members. Unsurprisingly, the Jagiellonian University staff have been honoured with a number of prestigious distinctions and awards, including the elite awards of the Foundation for Polish Science (‘Polish Nobel Prizes’) bestowed upon JU professors: Jan Wolenski, Tomasz Guzik, and Jan Potempa during the years 2010–2013. Additionally, the University was also recognised by the international databases Web of Science and Elsevier Scopus as possessing the most prolific researchers in Poland, publishing the most academic papers. In 2018, it was the only Polish and Eastern European higher education institution in Reuter’s Top 100: Europe’s Most Innovative Universities ranking.

D.Sc Unknown

King's College London was founded by King George IV and the Duke of Wellington (then Prime Minister) in 1829 as a university college in the tradition of the Church of England. It now welcomes staff and students of all faiths and beliefs.

Career History
Professor
Current

The Ohio State University College of Medicine (formerly known as The Ohio State University College of Medicine and Public Health) is the medical school at The Ohio State University and is located in Columbus, Ohio. The college is nationally recognized as a top institution in both education and research, as reflected by rankings in U.S. News & World Report. In 2009, its primary teaching hospital (Ohio State University Hospital) was ranked as one of the best hospitals in the U.S. in 10 different specialties; it was chosen to be among the 21 hospitals named to U.S. News & World Report's select honor roll of U.S. hospitals.

President & Chief Executive Officer
2020 - Current
Founder
2013 - Current

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.

Investments
Details Hidden

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Cambridge, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Krystof S. Bankiewicz. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Krystof S. Bankiewicz's profile does not indicate a business or promotional relationship of any kind between RelSci and Krystof S. Bankiewicz.